Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes
Authors
Keywords
-
Journal
BRAIN
Volume 138, Issue 4, Pages 918-931
Publisher
Oxford University Press (OUP)
Online
2015-02-17
DOI
10.1093/brain/awv017
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- YKL-40 Protein Levels and Clinical Outcome of Human Endometrial Cancer
- (2013) C Peng et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis
- (2013) Charlotte Teunissen et al. Multiple Sclerosis Journal
- High YKL-40 levels predict mortality in patients with type 2 diabetes
- (2012) Frederik Persson et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Serum YKL-40 Levels Correlate with Infarct Volume, Stroke Severity, and Functional Outcome in Acute Ischemic Stroke Patients
- (2012) Hyun Young Park et al. PLoS One
- The CD14bright CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population
- (2011) Manuela Rossol et al. ARTHRITIS AND RHEUMATISM
- Plasma level of chitinase 3-like 1 protein increases in patients with early Alzheimer’s disease
- (2011) Jihye Choi et al. JOURNAL OF NEUROLOGY
- Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis
- (2011) E Cantó et al. Multiple Sclerosis Journal
- Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas
- (2011) F. M. Iwamoto et al. NEURO-ONCOLOGY
- Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease
- (2011) Richard J. Perrin et al. PLoS One
- Increased YKL-40 expression in patients with carotid atherosclerosis
- (2010) Annika E. Michelsen et al. ATHEROSCLEROSIS
- YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease
- (2010) Rebecca Craig-Schapiro et al. BIOLOGICAL PSYCHIATRY
- Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis
- (2010) Manuel Comabella et al. BRAIN
- Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer
- (2010) Ina Thöm et al. CANCER
- Role of CCR5 and its ligands in the control of vascular inflammation and leukocyte recruitment required for acute excitotoxic seizure induction and neural damage
- (2010) Jean-Pierre Louboutin et al. FASEB JOURNAL
- The Chitinase-like Protein YKL-40 Is Secreted by Airway Epithelial Cells at Base Line and in Response to Compressive Mechanical Stress
- (2010) Jin-Ah Park et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases
- (2010) Dafna Bonneh-Barkay et al. Journal of Neuroinflammation
- Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosis
- (2010) Jorge Correale et al. Multiple Sclerosis Journal
- Overexpression of YKL-40 is an independent prognostic marker in gastric cancer
- (2009) Jiong Bi et al. HUMAN PATHOLOGY
- A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
- (2009) C. E. Teunissen et al. NEUROLOGY
- YKL-40 is Elevated in Morbidly Obese Patients and Declines After Weight Loss
- (2009) Moritz Hempen et al. OBESITY SURGERY
- YKL-40, a Marker of Simian Immunodeficiency Virus Encephalitis, Modulates the Biological Activity of Basic Fibroblast Growth Factor
- (2008) Dafna Bonneh-Barkay et al. AMERICAN JOURNAL OF PATHOLOGY
- Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis
- (2008) L. K. Fisniku et al. BRAIN
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More